Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aetna Members To Exclusively Use Specialty Pharmacy Joint Venture By October

This article was originally published in The Pink Sheet Daily

Executive Summary

The Aetna/Priority Healthcare joint venture’s Orlando, Fla. distribution center will begin servicing Aetna members in the first quarter. Aetna says it will switch all members who use specialty medicines from other distributors to Aetna Specialty Pharmacy by the end of the third quarter.

You may also be interested in...



Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition

Combination of CuraScript and Priority Healthcare will have sales of over $3 bil. Acquisition will provide CuraScript with access to new therapies, including those in fertility, hemophilia, home infusion, pulmonary hypertension and pulmonary fibrosis.

Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition

Combination of CuraScript and Priority Healthcare will have sales of over $3 bil. Acquisition will provide CuraScript with access to new therapies, including those in fertility, hemophilia, home infusion, pulmonary hypertension and pulmonary fibrosis.

Aetna Seeks To Serve As National Rx Drug Plan Under Medicare Part D

The company is the first large health plan to announce its intent to market a national PDP directly to individual Medicare beneficiaries. Aetna Pharmacy Management, the insurer's in-house PBM, will administer the benefit.

Related Content

Topics

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel